Skip to main content
. 2020 Mar 26;20:248. doi: 10.1186/s12879-020-4933-z

Table 2.

Resistance by ART Status and drug class, North West Province, South Africa, 2014a

Analyte Positivec ART experienced,b analyte negative ART naïveb Total
Percent 95% CI Percent 95% CI Percent 95% CI Percent 95% CI
Genotype result wgt na = 2643 wgt na = 677 wgt na = 4623 wgt na = 7943
 No resistance 24.4 14.4–38.3 49.0 10.7–88.4 72.6 55.2–85.1 54.6 43.4–65.4
 Any resistance 21.3 9.1–42.4 51.1 11.6–89.3 6.3 2.4–15.5 15.1 8.2–26.3
 Genotyping failure 54.3 35.4–72.0 0.0 21.1 9.4–40.7 30.3 20.3–42.6
Resistance - among those genotyped wgt na = 1209 wgt na = 677 wgt na = 3650 wgt na = 5536
 No resistance 53.4 30.0–75.7 49.0 10.7–88.4 92.0 81.0–96.9 78.3 64.3–87.9
 Any resistance 46.6 24.6–70.0 51.1 11.6–89.3 8.0 3.1–18.9 21.7 12.1–35.7
Drug class resistance wgt na = 564 wgt na = 346 wgt na = 291 wgt na = 1201
 Single class
  NRTI only 0.0 0.0 0.0 0.0
  NNRTI only 0.0 73.1 27.9–95.0 63.0 18.1–92.9 36.3 17.7–60.2
  PI only 0.0 12.2 1.4–58.6 11.5 1.2–58.0 6.3 1.3–25.7
 Dual class
  NRTI/NNRTI 100.0 14.7 1.6–64.1 0.0 51.2 28.3–73.6
  PI/NRTI 0.0 0.0 25.5 3.3–77.6 6.2 0.7–37.3
  PI/NNRTI 0.0 0.0 0.0 0.0

aWeights account for sampling, non-response, and age/sex of target population, bBy self report, c Assessed EFV, LPV, NVP